Bio Korea in May 2025

WHAT

Swedish companies have several opportunities to engage with and benefit from the Korean life science industry, leveraging the strengths and collaborative potential of both countries. Here are key opportunities for Swedish companies:

  • Clinical Trials

Swedish pharmaceutical and biotech companies can take advantage of Korea's efficient regulatory environment and strong clinical trial infrastructure to conduct clinical trials. Korea's proven track record in successful clinical research can accelerate the development and approval of new drugs.

  • Biopharmaceutical Manufacturing (CDMO)

Swedish companies can collaborate with leading Korean biopharmaceutical manufacturers like Samsung Biologics and Celltrion. Outsourcing production or forming joint ventures can enhance manufacturing capabilities and meet global demand.

  • Technology Transfer

There is potential for technology transfer in areas such as precision medicine, regenerative medicine, and gene therapy. Swedish innovations can be brought to the Korean market through licensing agreements or technology partnerships.

  • Health Tech and Digital Health

With both countries showing strong capabilities in digital technologies, there is significant potential for collaboration in health tech, including telemedicine, digital diagnostics, and health data analytics.

By capitalizing on these opportunities, Swedish companies can not only expand their presence in Asia but also contribute to and benefit from the dynamic and innovative Korean life science industry.

HOW

Swedish companies can benefit significantly from the Korean life science industry through various strategic approaches and opportunities.  

    1. Partnerships and Collaborations
  • Joint Research Projects: Collaborate on cutting-edge research with Korean universities and research institutions, leveraging Korea's advanced infrastructure and Sweden's scientific expertise.
  • Commercial Partnerships: Form alliances with Korean biotech and pharmaceutical companies to co-develop and market new products.
    1. Access to Advanced Technology and Innovation
  • Technology Exchange: Benefit from Korea's advancements in biotechnology, regenerative medicine, and gene therapy through technology transfer agreements.
  • Innovation Hubs: Establish R&D centers or innovation hubs in Korea to tap into local talent and innovative ecosystems.
    1. Efficient Clinical Trials and Regulatory Approvals
  • Clinical Trials: Conduct clinical trials in Korea to benefit from the country’s efficient regulatory processes and high-quality infrastructure, potentially accelerating time-to-market for new therapies.
  • Regulatory Navigation: Utilize Korea's regulatory expertise to facilitate smoother entry into other Asian markets with similar regulatory frameworks.
    1. Manufacturing and Production Capabilities
  • Biopharmaceutical Manufacturing: Collaborate with or outsource to leading Korean manufacturers like Samsung Biologics and Celltrion, taking advantage of their state-of-the-art production facilities and expertise in biosimilars and biopharmaceuticals.
  • Cost Efficiency: Benefit from potentially lower production costs in Korea compared to Western countries, while maintaining high manufacturing standards.
    1. Health Tech and Digital Health Collaboration
  • Digital Health Innovations: Partner with Korean firms to develop and implement digital health solutions, such as telemedicine platforms, digital diagnostics, and health data analytics, capitalizing on both countries' strengths in technology.
  • Smart Healthcare Solutions: Co-develop smart healthcare devices and systems that can be marketed globally, leveraging Sweden's design expertise and Korea's technology prowess.

By leveraging these opportunities, Swedish companies can enhance their global competitiveness, drive innovation, and achieve growth in the dynamic and rapidly evolving Korean life science industry.

In May 2025 Business Sweden will organize a tailor-made delegation program for Swedish life science companies to facilitate collaboration between Sweden and South Korea at Bio Korea in May 2025.

 
Contact us

For more information contact Bong-soon Park at bong-soon.park@business-sweden.se.